Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2026-05-18 @ 11:20 AM
Study NCT ID:
NCT00930605
Status:
COMPLETED
Last Update Posted:
2011-10-06
First Post:
2009-06-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Effectiveness of Alemtuzumab Given in Combination With CHOP and ESHAP in Patients Newly Diagnosed With Peripheral T-Cell Lymphoma (PTCL)
Sponsor:
Organization: